Shire (SHPG) Announces NEJM Publishes Phase 1b Results for Investigational Treatment for Hereditary Angioedema
Tweet Send to a Friend
Shire plc (NASDAQ: SHPG), the global leader in rare diseases, today announced the publication of results from the Phase 1b ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
